Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juli 2022

Genmab — Juli 2022

Planlagt Fastgjort Låst Flyttet Genmab
808 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #660

    EMA Orphan designation: Teclistamab for the: Treatment of multiple myeloma, 19/07/2022, Withdrawn (updated) -any idea why JNJ would do that? Any disadvantages for commercialisation i am unaware off?

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #661

      Positive opinion granted! There is your good news for the friday 🙂

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #662

        Thanks E L . 🙂

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #663

          The bad news is the new name, Tecvayli, ffs who makes these up 😄

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #664

            Link Preview Image
            Page or document not found | European Medicines Agency (EMA)

            We are sorry, but the content you tried to access is unavailable at the link you used, which was either incorrect or out-of-date. To help you find what you are looking for, we have included some useful tips.

            favicon

            European Medicines Agency (EMA) (www.ema.europa.eu)

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Stroka
              wrote on sidst redigeret af
              #665

              Ingen reaktion på aktiekursen.

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #666

                E L regarding the ODD withdrawned it could be due to the marked size being bigger than expected.

                1 Reply Last reply
                0
                • D Offline
                  D Offline
                  deleted-user
                  wrote on sidst redigeret af
                  #667

                  Thx E L you never disappoint likewise Genmab

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #668

                    Thx. OK, thx, I was thinking in the same direction Sukkeralf. I am even thinking, IF they would broaden the indication outside of myeloma at some point, and that way reach more patients in total, if they would then loose orphan for myeloma anyway

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #669

                      But anyway, who cares, product #6 on it's way

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #670

                        Yes indeed fantastic and admirable

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          bibob
                          wrote on sidst redigeret af
                          #671

                          Ikke helt med Genmab. 😉

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            JKY_VH
                            wrote on sidst redigeret af
                            #672

                            Jep, Genmab fortsat i grønt

                            1 Reply Last reply
                            0
                            • D Offline
                              D Offline
                              Doublo
                              wrote on sidst redigeret af
                              #673

                              God morgen 🙂 Ja og udover den dejlige stigning på Genmab har der endelig været lidt positiv bevægelse i A.P. Møller som jeg desværre/heldigvis? har en hulens masse af!!

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                bibob
                                wrote on sidst redigeret af
                                #674

                                Historisk Vinge( gaard) sus. 😄

                                1 Reply Last reply
                                0
                                • J Offline
                                  J Offline
                                  JKY_VH
                                  wrote on sidst redigeret af
                                  #675

                                  Ja, det var flot bibob;-)

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #676

                                    the Japanese Epcoritamab trial starts recruiting again, with a few additional arms added https://www.clinicaltrials.gov/ct2/history/NCT04542824?A=5&B=6&C=merged#StudyPageTop

                                    1 Reply Last reply
                                    0
                                    • bongobobB Offline
                                      bongobobB Offline
                                      bongobob
                                      wrote on sidst redigeret af
                                      #677

                                      Thanks EL. Apparently Genmab has 21 investigational sites in Japan. Is that with staff or just agreements with clinics

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #678

                                        no, they are all hospitals; you can see that in the earlier version they mentioned the names of the hospitals. I don't know why they changed it to read like this , but have seen it in more trials with other companies also

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          ProinvestorNEWS
                                          wrote on sidst redigeret af
                                          #679

                                          Akter/middag: Bavarian rykker på godkendelse - banker kommer lidt igen https://www.proinvestor.com/investornyt/854869/akter-middag-bavarian-rykker-pa-godkendelse-banker-kommer-lidt-igen

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper